Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Catalyzed Chiral Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109516998B details a novel synthesis method for Baloxavir intermediate with mild conditions and high chiral purity without resolution steps enabling significant cost savings and enhanced supply chain reliability.